Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Hepatology ; 49(5): 1515-24, 2009 May.
Article in English | MEDLINE | ID: mdl-19205031

ABSTRACT

UNLABELLED: Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) occurs predominantly in men. By enhancing the transcriptional activity of the androgen receptor (AR) gene in a ligand-dependent manner, the HBV X protein (HBx) might contribute to this disparity between sexes. To dissect the mechanisms underlying HBx-enhanced AR transactivation, we investigated the effect of HBx on two critical steps in the regulation of ligand-stimulated AR activities. One step is the dimerization of AR (through the interaction of its N-termini and C-termini), and the other step is the activation of the AR N-terminal transactivation domain (NTD). HBx increased the NTD activation of the AR through c-Src kinase. HBx also enhanced AR dimerization by inhibiting glycogen synthase kinase-3beta (GSK-3beta) activity, which acts as a negative regulator of the interaction between AR and the N-termini and C-termini. The HBx-enhanced AR transactivation was abolished by blocking c-Src and activating GSK-3beta kinases simultaneously, suggesting that these two kinases act as major switches in the activation process. The regulatory function of both kinases has been further verified in primary hepatocytes isolated from the livers of HBx transgenic male mice. CONCLUSION: Our study thus identified two key kinases through which HBx enhances the AR transcriptional activity. These kinases might be potential candidates for future prevention or therapy for HBV-related HCC in men.


Subject(s)
Glycogen Synthase Kinase 3/metabolism , Protein-Tyrosine Kinases/metabolism , Proto-Oncogene Proteins/metabolism , Receptors, Androgen/metabolism , Trans-Activators/metabolism , Transcriptional Activation , Viral Regulatory and Accessory Proteins/metabolism , Animals , CSK Tyrosine-Protein Kinase , Cell Line, Tumor , Glycogen Synthase Kinase 3 beta , Hepatitis B/metabolism , Humans , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Phosphorylation , Protein Interaction Domains and Motifs , Sex Characteristics , src-Family Kinases
2.
Proc Natl Acad Sci U S A ; 104(8): 2571-8, 2007 Feb 20.
Article in English | MEDLINE | ID: mdl-17259306

ABSTRACT

Persistent hepatitis B virus (HBV) infection is a major risk of hepatocellular carcinoma (HCC). One intriguing feature of HBV-related HCC is the male predominance, with a male to female ratio of 5-7:1. This dominance has been attributed to the elevated androgen level and the enhanced androgen receptor (AR)-mediated activity in the host. How HBV infection and AR signaling modulate HCC is unknown. We investigated whether the HBV nonstructural protein, X protein (HBx) could cooperate with the AR signaling pathway to enhance carcinogenesis. We found that HBx increased the anchorage-independent colony-formation potency of AR in a nontransformed mouse hepatocyte cell line. We also found that HBx functioned as a positive transcriptional coregulator to increase AR-mediated transcriptional activity. This transcription enhancement was increased in the presence of androgen in a concentration-responsive manner, thus explaining a more prominent effect in males. HBx did not physically associate with ligand-bound AR in the nucleus, and it likely augmented AR activity by increasing the phosphorylation of AR through HBx-mediated activation of the c-Src kinase signaling pathway. Our study documents HBx as a previously undescribed class of noncellular positive coregulators for AR. The results reveal a mechanism for the vulnerability of males to microbial infections and the subsequent development of cancer.


Subject(s)
Androgens/metabolism , Gene Expression Regulation , Hepatitis B virus/metabolism , Receptors, Androgen/genetics , Receptors, Androgen/metabolism , Trans-Activators/metabolism , Androgens/pharmacology , Animals , Cell Line, Transformed , Cell Nucleus/drug effects , Cell Nucleus/metabolism , Cytosol/drug effects , Cytosol/metabolism , Dose-Response Relationship, Drug , Hepatitis B , Hepatocytes/drug effects , Hepatocytes/metabolism , Humans , Male , Mice , Models, Biological , Phosphorylation/drug effects , Protein Binding/drug effects , Protein Structure, Tertiary/drug effects , Proto-Oncogene Proteins pp60(c-src)/metabolism , Receptors, Androgen/chemistry , Stem Cells , Trans-Activators/chemistry , Viral Regulatory and Accessory Proteins
SELECTION OF CITATIONS
SEARCH DETAIL